Impact of SARS-CoV-2 on Pregnancy Outcomes (Review)

Overview

Journal Med Int (Lond)

Publisher Spandidos Publications

Specialty General Medicine

Date 2023 Jan 26

PMID 36698529

Authors

Panagiotis Tsikouras

Vasiliki Kourti

Aggeliki Gerede

Eleni Kiosse

Maria Panopoulou

Stefanos Zervoudis

Anastasia Bothou

George Iatrakis

Fotini Gaitatzi

Xanthi Vatsidou

Anna Chalkidou

Konstantinos Nikolettos

Alexis Alexiou

Panagiotis Peitsidis

Maria Lambropoulou

Spyridon Michalopoulos

Nikolaos Nikolettos

Petros Rafailidis

Affiliations

Soon will be listed here.

Abstract

The impact of the pandemic outbreak associated with coronavirus 2019 disease (COVID-19) on pregnant women is of interest to obstetricians and gynecologists due to the vulnerability of this target group. In pregnant women and their infants, an exceptional clinical management is warranted. Current epidemiological findings provide information regarding the effects of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) on pregnant patients and potential adverse perinatal outcomes. Overall, these findings are a strong indication that an increased antenatal surveillance for pregnant patients infected with COVID-19 is warranted. The aim of the present narrative review was to summarize the data obtained to date regarding the health of women during pregnancy, as well as that of the fetus associated with the risk of severe infection due to COVID-19. The present review aimed to provide further insight into the effects of this pandemic on pregnancy, also providing the experience of the authors on this matter as an example.

Citing Articles

Risk of Transmission of COVID-19 from the Mother to the Foetus: A Systematic Review.

Palaska E, Golia E, Zacharogianni E, Bothou A, Tziriridou-Chatzopoulou M, Dagla M J Mother Child. 2024; 28(1):94-101.

PMID: 39561303 PMC: 11575933. DOI: 10.34763/jmotherandchild.20242801.d-24-00032.

References

Aliji N, Aliu F . Oligohydramnion in COVID19. Eur J Obstet Gynecol Reprod Biol. 2020; 249:102. PMC: 10283075. DOI: 10.1016/j.ejogrb.2020.04.047. View

Rohr S, Muller F, Jung F, Apfelbacher C, Seidler A, Riedel-Heller S . [Psychosocial Impact of Quarantine Measures During Serious Coronavirus Outbreaks: A Rapid Review]. Psychiatr Prax. 2020; 47(4):179-189. PMC: 7295307. DOI: 10.1055/a-1159-5562. View

Chew N, Lee G, Tan B, Jing M, Goh Y, Ngiam N . A multinational, multicentre study on the psychological outcomes and associated physical symptoms amongst healthcare workers during COVID-19 outbreak. Brain Behav Immun. 2020; 88:559-565. PMC: 7172854. DOI: 10.1016/j.bbi.2020.04.049. View

Cao B, Wang Y, Wen D, Liu W, Wang J, Fan G . A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19. N Engl J Med. 2020; 382(19):1787-1799. PMC: 7121492. DOI: 10.1056/NEJMoa2001282. View

Dashraath P, Wong J, Lim M, Lim L, Li S, Biswas A . Coronavirus disease 2019 (COVID-19) pandemic and pregnancy. Am J Obstet Gynecol. 2020; 222(6):521-531. PMC: 7270569. DOI: 10.1016/j.ajog.2020.03.021. View

Shanes E, Otero S, Mithal L, Mupanomunda C, Miller E, Goldstein J . Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccination in Pregnancy: Measures of Immunity and Placental Histopathology. Obstet Gynecol. 2021; 138(2):281-283. PMC: 8288194. DOI: 10.1097/AOG.0000000000004457. View

Yeo C, Kaushal S, Yeo D . Enteric involvement of coronaviruses: is faecal-oral transmission of SARS-CoV-2 possible?. Lancet Gastroenterol Hepatol. 2020; 5(4):335-337. PMC: 7130008. DOI: 10.1016/S2468-1253(20)30048-0. View

Juan J, Gil M, Rong Z, Zhang Y, Yang H, Poon L . Effect of coronavirus disease 2019 (COVID-19) on maternal, perinatal and neonatal outcome: systematic review. Ultrasound Obstet Gynecol. 2020; 56(1):15-27. PMC: 7276742. DOI: 10.1002/uog.22088. View

Ord M, Faustova I, Loog M . The sequence at Spike S1/S2 site enables cleavage by furin and phospho-regulation in SARS-CoV2 but not in SARS-CoV1 or MERS-CoV. Sci Rep. 2020; 10(1):16944. PMC: 7547067. DOI: 10.1038/s41598-020-74101-0. View

10.

Yan Y, Chang L, Wang L . Laboratory testing of SARS-CoV, MERS-CoV, and SARS-CoV-2 (2019-nCoV): Current status, challenges, and countermeasures. Rev Med Virol. 2020; 30(3):e2106. PMC: 7235496. DOI: 10.1002/rmv.2106. View

11.

Deeks J, Dinnes J, Takwoingi Y, Davenport C, Spijker R, Taylor-Phillips S . Antibody tests for identification of current and past infection with SARS-CoV-2. Cochrane Database Syst Rev. 2020; 6:CD013652. PMC: 7387103. DOI: 10.1002/14651858.CD013652. View

12.

Dennis A, Hardy L, Leeton L . The prone position in healthy pregnant women and in women with preeclampsia - a pilot study. BMC Pregnancy Childbirth. 2018; 18(1):445. PMC: 6240306. DOI: 10.1186/s12884-018-2073-x. View

13.

Guo Y, Cao Q, Hong Z, Tan Y, Chen S, Jin H . The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak - an update on the status. Mil Med Res. 2020; 7(1):11. PMC: 7068984. DOI: 10.1186/s40779-020-00240-0. View

14.

McIntosh J . Corticosteroid Guidance for Pregnancy during COVID-19 Pandemic. Am J Perinatol. 2020; 37(8):809-812. PMC: 7356057. DOI: 10.1055/s-0040-1709684. View

15.

Li C, Ren L . Recent progress on the diagnosis of 2019 Novel Coronavirus. Transbound Emerg Dis. 2020; 67(4):1485-1491. PMC: 7272792. DOI: 10.1111/tbed.13620. View

16.

Fakari F, Simbar M . Coronavirus Pandemic and Worries during Pregnancy; a Letter to Editor. Arch Acad Emerg Med. 2020; 8(1):e21. PMC: 7075675. View

17.

Hiremath P, Suhas Kowshik C, Manjunath M, Shettar M . COVID 19: Impact of lock-down on mental health and tips to overcome. Asian J Psychiatr. 2020; 51:102088. PMC: 7151434. DOI: 10.1016/j.ajp.2020.102088. View

18.

McCreary E, Pogue J . Coronavirus Disease 2019 Treatment: A Review of Early and Emerging Options. Open Forum Infect Dis. 2020; 7(4):ofaa105. PMC: 7144823. DOI: 10.1093/ofid/ofaa105. View

19.

Elshafeey F, Magdi R, Hindi N, Elshebiny M, Farrag N, Mahdy S . A systematic scoping review of COVID-19 during pregnancy and childbirth. Int J Gynaecol Obstet. 2020; 150(1):47-52. PMC: 9087748. DOI: 10.1002/ijgo.13182. View

20.

Wang M, Cao R, Zhang L, Yang X, Liu J, Xu M . Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res. 2020; 30(3):269-271. PMC: 7054408. DOI: 10.1038/s41422-020-0282-0. View